Preliminary results from a phase 1 study of AB122, a programmed cell death-1 (PD-1) inhibitor, in patients with advanced solid malignancies
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-12, Vol.29, p.x28-x28 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | x28 |
|---|---|
| container_issue | |
| container_start_page | x28 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Seitz, L.C. Rieger, A. Berry, W. Ashok, D. Direnzo, D. Jin, L. Lee, S.J. Park, A. Piovesan, D. Tan, J.B.L. Walters, M.J. Karakunnel, J. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy487.008 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy487_008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419326900</els_id><sourcerecordid>S0923753419326900</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1858-1c215394688bb40adb2d589611f0937c197b72b7768137a568a4253b53f87d033</originalsourceid><addsrcrecordid>eNp9kE1OwzAQRi0EEqVwAHZegkRaj53EtliV8itVogtYR07sNEaJU9lpUc_ApXEV1qxmNKP3aeYhdA1kBkSyuXKud9W804dU8Bkh4gRNIMtlIkgKp2hCJGUJz1h6ji5C-CKE5JLKCfpZe9PazjrlD9ibsGuHgGvfd1jhbaOCwYDDsNMH3Nd48QCU3h03vt941XVG48q0LdZGDU0C-Gb9mMAttq6xpR16fxdbvFWDNS7GftuhwUrvlasiGPrWatyp1m5cnFgTLtFZrdpgrv7qFH0-P30sX5PV-8vbcrFKKhCZSKCikDGZ5kKUZUqULqnOhMwB6miCVyB5yWnJeS6AcZXlQqU0Y2XGasE1YWyKYMytfB-CN3Wx9baLAgogxdFmMdosRptFtBmZ-5Ex8bC9Nb4I8eTjI9abaih0b_-hfwGtV36F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preliminary results from a phase 1 study of AB122, a programmed cell death-1 (PD-1) inhibitor, in patients with advanced solid malignancies</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Seitz, L.C. ; Rieger, A. ; Berry, W. ; Ashok, D. ; Direnzo, D. ; Jin, L. ; Lee, S.J. ; Park, A. ; Piovesan, D. ; Tan, J.B.L. ; Walters, M.J. ; Karakunnel, J.</creator><creatorcontrib>Seitz, L.C. ; Rieger, A. ; Berry, W. ; Ashok, D. ; Direnzo, D. ; Jin, L. ; Lee, S.J. ; Park, A. ; Piovesan, D. ; Tan, J.B.L. ; Walters, M.J. ; Karakunnel, J.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy487.008</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-12, Vol.29, p.x28-x28</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1858-1c215394688bb40adb2d589611f0937c197b72b7768137a568a4253b53f87d033</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Seitz, L.C.</creatorcontrib><creatorcontrib>Rieger, A.</creatorcontrib><creatorcontrib>Berry, W.</creatorcontrib><creatorcontrib>Ashok, D.</creatorcontrib><creatorcontrib>Direnzo, D.</creatorcontrib><creatorcontrib>Jin, L.</creatorcontrib><creatorcontrib>Lee, S.J.</creatorcontrib><creatorcontrib>Park, A.</creatorcontrib><creatorcontrib>Piovesan, D.</creatorcontrib><creatorcontrib>Tan, J.B.L.</creatorcontrib><creatorcontrib>Walters, M.J.</creatorcontrib><creatorcontrib>Karakunnel, J.</creatorcontrib><title>Preliminary results from a phase 1 study of AB122, a programmed cell death-1 (PD-1) inhibitor, in patients with advanced solid malignancies</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE1OwzAQRi0EEqVwAHZegkRaj53EtliV8itVogtYR07sNEaJU9lpUc_ApXEV1qxmNKP3aeYhdA1kBkSyuXKud9W804dU8Bkh4gRNIMtlIkgKp2hCJGUJz1h6ji5C-CKE5JLKCfpZe9PazjrlD9ibsGuHgGvfd1jhbaOCwYDDsNMH3Nd48QCU3h03vt941XVG48q0LdZGDU0C-Gb9mMAttq6xpR16fxdbvFWDNS7GftuhwUrvlasiGPrWatyp1m5cnFgTLtFZrdpgrv7qFH0-P30sX5PV-8vbcrFKKhCZSKCikDGZ5kKUZUqULqnOhMwB6miCVyB5yWnJeS6AcZXlQqU0Y2XGasE1YWyKYMytfB-CN3Wx9baLAgogxdFmMdosRptFtBmZ-5Ex8bC9Nb4I8eTjI9abaih0b_-hfwGtV36F</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Seitz, L.C.</creator><creator>Rieger, A.</creator><creator>Berry, W.</creator><creator>Ashok, D.</creator><creator>Direnzo, D.</creator><creator>Jin, L.</creator><creator>Lee, S.J.</creator><creator>Park, A.</creator><creator>Piovesan, D.</creator><creator>Tan, J.B.L.</creator><creator>Walters, M.J.</creator><creator>Karakunnel, J.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201812</creationdate><title>Preliminary results from a phase 1 study of AB122, a programmed cell death-1 (PD-1) inhibitor, in patients with advanced solid malignancies</title><author>Seitz, L.C. ; Rieger, A. ; Berry, W. ; Ashok, D. ; Direnzo, D. ; Jin, L. ; Lee, S.J. ; Park, A. ; Piovesan, D. ; Tan, J.B.L. ; Walters, M.J. ; Karakunnel, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1858-1c215394688bb40adb2d589611f0937c197b72b7768137a568a4253b53f87d033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seitz, L.C.</creatorcontrib><creatorcontrib>Rieger, A.</creatorcontrib><creatorcontrib>Berry, W.</creatorcontrib><creatorcontrib>Ashok, D.</creatorcontrib><creatorcontrib>Direnzo, D.</creatorcontrib><creatorcontrib>Jin, L.</creatorcontrib><creatorcontrib>Lee, S.J.</creatorcontrib><creatorcontrib>Park, A.</creatorcontrib><creatorcontrib>Piovesan, D.</creatorcontrib><creatorcontrib>Tan, J.B.L.</creatorcontrib><creatorcontrib>Walters, M.J.</creatorcontrib><creatorcontrib>Karakunnel, J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seitz, L.C.</au><au>Rieger, A.</au><au>Berry, W.</au><au>Ashok, D.</au><au>Direnzo, D.</au><au>Jin, L.</au><au>Lee, S.J.</au><au>Park, A.</au><au>Piovesan, D.</au><au>Tan, J.B.L.</au><au>Walters, M.J.</au><au>Karakunnel, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preliminary results from a phase 1 study of AB122, a programmed cell death-1 (PD-1) inhibitor, in patients with advanced solid malignancies</atitle><jtitle>Annals of oncology</jtitle><date>2018-12</date><risdate>2018</risdate><volume>29</volume><spage>x28</spage><epage>x28</epage><pages>x28-x28</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdy487.008</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-12, Vol.29, p.x28-x28 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy487_008 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Preliminary results from a phase 1 study of AB122, a programmed cell death-1 (PD-1) inhibitor, in patients with advanced solid malignancies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A00%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preliminary%20results%20from%20a%20phase%201%20study%20of%20AB122,%20a%20programmed%20cell%20death-1%20(PD-1)%20inhibitor,%20in%20patients%20with%20advanced%20solid%20malignancies&rft.jtitle=Annals%20of%20oncology&rft.au=Seitz,%20L.C.&rft.date=2018-12&rft.volume=29&rft.spage=x28&rft.epage=x28&rft.pages=x28-x28&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy487.008&rft_dat=%3Celsevier_cross%3ES0923753419326900%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419326900&rfr_iscdi=true |